Evidence that moves from laboratory insight to patient impact.
AFEREI prioritizes fertility preservation, reproductive biotechnology, embryology excellence, and multicenter data generation relevant to African populations and health systems.
Eight priority domains for fertility science in Africa.
The portfolio is intentionally translational, connecting preservation techniques, embryo biology, data systems, and reproductive endocrinology to clinical and public health realities.
Priority 1
Fertility Preservation
Advance OTC, IVM, and integrated fertility preservation pathways for oncology and high-risk infertility populations.
Priority 2
Reproductive Genetics
Investigate genetic determinants of fertility, embryo competence, and diagnostic applications relevant to African populations.
Priority 3
ART Outcomes Research
Generate evidence on treatment outcomes, access barriers, lab quality markers, and patient-centered success metrics.
Priority 4
Biobanking & Cryopreservation
Strengthen specimen preservation, storage standards, and translational research infrastructure.
Priority 5
Embryo Development & Epigenetics
Study embryo development patterns, epigenetic mechanisms, and implications for ART quality and offspring health.
Priority 6
Reproductive Endocrinology
Connect endocrine drivers, fertility diagnostics, and personalized treatment strategies.
Priority 7
Reproductive Biotechnology
Translate laboratory innovation into clinically useful, scalable reproductive technologies.
Priority 8
Multicenter Studies
Coordinate cross-institution infertility and cancer-related infertility research across African settings.